- November 4, 2019
- 1:00 PM - 4:00 PM ET
Event LocationSir Frederick G. Banting Research Centre
Health Canada ‑ US FDA Joint Consultation on ICH in Ottawa
251 Sir Frederick Banting Dr.
Ottawa ON K1Y 0M1
- Organized By:
The Food and Drug Administration (FDA) is announcing a regional public meeting entitled ‘‘Health Canada and United States Food and Drug Administration Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Human Use (ICH)’’ to provide information and receive comments on the current activities of ICH as well as the upcoming meetings in Singapore, November 2019. The topics to be discussed are the topics for discussion at the forthcoming ICH Assembly Meeting. The purpose of the public meeting is to solicit public input prior to the next ICH Assembly meeting and the expert working groups meetings in Singapore, scheduled for November 16 through 20, 2019, at which the discussion of the topics underway will continue.
Webcast (A website to access the webcast will be emailed to those who register for the meeting as a remote attendee – see Registration for details)
If you wish to attend the public meeting either in-person or via webcast, please register at the following website: Health Canada - US FDA Joint Consultation on ICH. Registrations may be limited, so early registration is recommended. Registration is free and will be on a first-come, first-served basis. However, the number of participants from each organization may be limited based on space limitations. Registrants will receive confirmation once they have been accepted.